Data / Form D filings / CARDIOXYL PHARMACEUTICALS INC
CARDIOXYL PHARMACEUTICALS INC: Form D filings
CARDIOXYL PHARMACEUTICALS INC, a pharmaceuticals company in Chapel Hill, NC, filed 3 Form D notices with the SEC between 2009 and 2012. The latest, on November 7, 2012, reports $28.1 million sold of a $28.1 million offering to 5 investors.
Find out what CARDIOXYL PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1450 RALEIGH ROAD, EXCHANGE EAST, SUITE 212, Chapel Hill, NC, 27517
- Phone
- (919) 869-8585
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1382014
The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 7, 2012 | New notice | $28,050,000 | $28,050,000 | $0 | 5 | Oct 24, 2012 | sec.gov |
| Jul 30, 2010 | New notice | $15,000,000 | $15,000,000 | $0 | 2 | Jul 15, 2010 | sec.gov |
| Aug 20, 2009 | New notice | $9,000,000 | $9,000,000 | $0 | 2 | Aug 5, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert A. Garland | Director | |
| Gary A. Stiles | Director | |
| James A. Barrett | Director | |
| Christopher A. Kroeger | Executive Officer, Director | |
| Doug A. Cowart | Executive Officer | |
| Anthony A. Johnson | Director | |
| Jeff A. Clark | Director | |
| John A. Reardon | Executive Officer | |
| Peter A. Thompson | Director | |
| Vince A. Kalish | Executive Officer |
Other pharmaceuticals companies in North Carolina that filed recently
- Dignify Therapeutics, LLC $800,000 · Sep 25, 2026
Every Form D from the week of Nov 5, 2012 · All recent filings in North Carolina · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what CARDIOXYL PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.